Related Experiment Videos
Reoperation for recurrent metastatic brain tumors
R K Bindal1, R Sawaya, M E Leavens
1Department of Neurosurgery, M. D. Anderson Cancer Center, Houston, Texas, USA.
Journal of Neurosurgery
|October 1, 1995
Summary
Reoperation for recurrent brain metastases can extend survival and improve quality of life. A new grading system based on five factors helps predict outcomes for patients undergoing repeat surgeries for brain tumors.
Area of Science:
- Neurosurgery
- Oncology
- Clinical Research
Background:
- Recurrent brain metastases pose a significant challenge in cancer management.
- Identifying prognostic factors for reoperation is crucial for patient care.
Purpose of the Study:
- To evaluate the outcomes of reoperation for recurrent brain metastases.
- To develop a prognostic grading system to predict survival after reoperation.
Main Methods:
- Retrospective analysis of 48 patients undergoing reoperation for recurrent brain metastases.
- Multivariate analysis to identify factors affecting survival.
- Development of a grading system (Grades I-IV) based on key prognostic factors.
Main Results:
- Median survival after reoperation was 11.5 months.
- Key negative prognostic factors included systemic disease, Karnofsky Performance Scale (KPS) ≤ 70, time to recurrence < 4 months, and primary tumor type (breast/melanoma).
- The developed grading system showed significant correlation with 5-year survival rates and median survival times.
Conclusions:
- Reoperation for recurrent brain metastases can prolong survival and improve quality of life.
- A second reoperation further increases survival.
- The five-factor grading system aids in patient selection and prognosis, guiding cautious reoperation in Grade IV patients.